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Despite the effectiveness of antiretroviral medication, the
HIV virus persists in resting memory T cells of infected
patients in a latent state, providing the main impediment
to eradication of the virus. We are interested in identifying
the molecular mechanism responsible for the establish-
ment and maintenance of HIV latency and its re-activa-
tion. We recently used a cell system reflecting HIV latency
in my lab to determine the high resolution nucleosomal
landscape of the latent HIV LTR and examine its dynamic
changes upon re-activation (Rafati et al., Nov 2011 PLoS
Biology). We combined mathematical predictions of
nucleosome positioning with a combinatorial biochemical
approach based on formaldehyde crosslinking of latent
and activated HIV infected cells (using FAIRE, ChIP and
high resolution MNase nucleosomal mapping) to define
LTR nucleosome positioning and regulation during active
and latent HIV infections. We found that BAF, an ATP-
dependent chromatin remodelling complex generates
a chromatin structure at the LTR that is energetically
unfavorable to its intrinsic histone-DNA sequence prefer-
ences. Specifically, we find that BAF positions a repressive
nucleosome immediately downstream of the HIV tran-
scription start site, abrogating transcription, and in this
way contributes to the establishment and maintenance of
HIV latency. Our data describe a novel molecular mechan-
ism for the establishment and maintenance of HIV
latency, and we identify the catalytic subunit of BAF, the
enzyme BRG1, as a putative molecular target to deplete
the latent reservoir in infected patients. We will also pre-
sent preliminary data addressing the role of a novel signal-
ling pathway in de-repression of latent HIV, and the effect
of small molecules and ligands, which activate this
pathway to study reactivation of latent HIV. We anticipate
these experiments will further our understanding of HIV
transcription regulation and identify both novel cofactors
for targeting and molecules with potential to purge HIV
latency.
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